Fox 5 New York
@fox5ny·983K subscribers·28K videos
Moderna and Merck personalized cancer vaccine succeeds in late-stage trial
Posted
August 20, 2026
Views
821
Likes
12
Comments
5
Engagement
August 20, 2026
821
12
5
2.07%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
1:45Now PlayingA personalized mRNA vaccine from Moderna and Merck, combined with Keytruda, met its main goal in a late-stage clinical trial for melanoma. The treatment significantly helped prevent high-risk skin cancer from returning compared to standard therapy.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
